• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Etanercept
    1 Drug classified under this active ingredient


    All the Active Ingredient Drugs

    Enbrel
    Pfizer
    RX
    partial basket chart
    Enbrel

    TNF Blocking Agent. Etanercept 25, 50 mg.
    VIAL (pwdr.& solvent ): 25 mg.
    PRE-FILL. SYR. (sol. for inj.): 1 x 25 mg;
    1 x 50 mg.
    PRE-FILL. PEN (sol. for inj.): 1 x 50 mg.
    Dosage must be ajust. individ.
    RA: Tmt. of active RA in adult. when the
    response to DMARDs include.
    methotrexate (unless contraindic. ) has
    been inadeq. Can be used in comb. with
    methotrexate in pts. who do not respond
    adeq. to methotrexate alone. Reduc.
    signs&sympt. and inhibit. the progress. of
    structur. damage in pts. with moder. –
    sev. act. RA.
    Alone or in comb. with methotrexate, has
    been shown to reduce the rate of
    progress. of joint damage as measure. by
    X-ray and to improve. physic. funct.
    Polyarticul. juven. idiopathic arthrit.:
    Tmt. of active polyarticul. juven.
    idiopathic arthrit. in child. & adolesc. ≥2
    yrs. who have had an inadeq. respon. to,
    or who have proved intoler. of,
    methotrexate. The drug has not been
    studi. in child. < 2 yrs.
    Psor. arthrit.: Tmt. of act. & progress. psor.
    arthrit. in adults when the response to
    prev. DMARDs ther. has been inadeq.
    The has been shown to improve. physic.
    func. in pts. with psoriat. arthrit., and to
    reduce the rate of progress. of peripher.
    joint damage as measured by X ray in pts.
    with polyarticul. symmetric. subtypes of
    the dis.
    Ankylos. spondyl.: Tmt. of adult. with sev.
    act. ankylos. spondyl. who have had an
    inadeq. response to convent. ther.
    Plaque psorias.: Tmt. of adults pts. (18 yrs.
    or older) with moderate to severe plaque
    psor. who are candidates for system. ther.
    or photother.
    Ped. plaque psor. Tmt. of chron. sev.
    plaque psor. in child. &adolesc. from the
    age of 6 yrs. who are inadeq. control. by,
    or are intoler. to, other system. ther. or
    photother.
    Juven. idiopat. arthrit. tmt. of polyarthrit.
    (rheumat. factor posit. or neg.) and
    extended oligoarthritis in child. &
    adolesc. ≥2 yrs who have had an inadeq. response to, or who have proved intoler.
    of, methotrexate.
    Tmt. of psor. arthrit. in adolesc. ≥12 yrs.
    who have had an inadeq. response to, or
    who have proved intol. of, methotrexate.
    Tmt. of enthesitis-related arthrit. in
    adolesc. ≥ 12 yrs. who have had an
    inadeq. respon. to, or who have proved
    intoler. of, convent. ther.
    Axial spondyloarthritis Ankylos.
    spondylitis: Tmt. of adults with sev. active
    ankylosing spondylitis who have had an
    inadeq. response to convent. ther.
    Non-radiograph. axial spondyloarthritis:
    Tmt. of adult. with sev. non-radiograph.
    axial spondyloarthritis with object. signs
    of inflamm. as indic. by elev. CRP and MRI
    evidence, who have had an inadeq.
    response to NSAIDs.
    C/I: Hypersens., sepsis or risk of sepsis,
    Pts. with active infec. , includ. chron. or
    localised infec.

    CLOSE